Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer’s disease

BACKGROUND: Recognizing clinical manifestations heralding the development of Alzheimer’s disease (AD)-related cognitive impairment could improve the identification of individuals at higher risk of AD who may benefit from potential prevention strategies targeting preclinical population. We aim to cha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Res Ther
Main Authors: Grau-Rivera, Oriol, Navalpotro-Gomez, Irene, Sánchez-Benavides, Gonzalo, Suárez-Calvet, Marc, Milà-Alomà, Marta, Arenaza-Urquijo, Eider M., Salvadó, Gemma, Sala-Vila, Aleix, Shekari, Mahnaz, González-de-Echávarri, José Maria, Minguillón, Carolina, Niñerola-Baizán, Aida, Perissinotti, Andrés, Simon, Maryline, Kollmorgen, Gwendlyn, Zetterberg, Henrik, Blennow, Kaj, Gispert, Juan Domingo, Molinuevo, José Luis
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7890889/
https://ncbi.nlm.nih.gov/pubmed/33597012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-021-00781-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados